Metraipolis › archive › dc_cc2d675c1a97
Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection — Europe PMC PMID:42104727
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42104727
- DOI
- 10.1002/ame2.70211
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T12:52:58.626Z
- SHA-256 of the archived text
0faef5f6abd34fc8e479b21f02f24f46b7cda52ed971e30954101bed1099d868- Stable URL of this page
https://metraipolis.com/documento/dc_cc2d675c1a97
How to cite
Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection — Europe PMC PMID:42104727 — Europe PMC (en), https://europepmc.org/article/MED/42104727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc2d675c1a97 (Metraipolis archive dc_cc2d675c1a97, sha256 0faef5f6abd34fc8e479b21f02f24f46b7cda52ed971e30954101bed1099d868)
BibTeX
@misc{dccc2d675c1a97,
title = {Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection — Europe PMC PMID:42104727},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42104727},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc2d675c1a97; sha256 0faef5f6abd34fc8e479b21f02f24f46b7cda52ed971e30954101bed1099d868},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42104727. Agents can read the archived copy with the MCP tool read_document.